Connect Biopharma Holdings Ltd ADR (NQ: CNTB )
1.000
-0.110
(-9.91%)
Streaming Delayed Price
Updated: 1:27 PM EST, Nov 18, 2024
Add to My Watchlist
Headline News about Connect Biopharma Holdings Ltd ADR
Week In Review: EpimAb Sells T-Cell Engager In $635 Million Deal
September 07, 2024
Via Talk Markets
Via Benzinga
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
February 20, 2024
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
February 02, 2024
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
January 23, 2024
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 29, 2023
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
December 11, 2023
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
November 21, 2023
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
November 21, 2023
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
November 17, 2023
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
November 02, 2023
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
October 27, 2023
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
October 02, 2023
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
September 22, 2023
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
August 21, 2023
Via Benzinga
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free